Bioregulators Khavinson bioregulator tetrapeptideNot FDA-approved · research compound

Prostamax

Prostamax (Khavinson)

Evidence: Studied in humans. Example dose: finalize with a provider. Not a fact-check stamp.

500 mcg daily SubQ 12 week course, monitor PSA

10-20 mg Oral Daily

Prostate tissue regulatorGene expression modulator

Prostamax (Lys-Glu-Asp-Pro) is a Khavinson bioregulator tetrapeptide targeting prostate tissue gene expression. It supports prostatic epithelial cell function, hormonal receptor balance, and prostate tissue maintenance. Developed for age-related prostate changes and benign prostatic hyperplasia (BPH) support.

Quick Start

Route

SubQ injection

Start low

500 mcg SubQ

Frequency

12 week course, monitor PSA

Timing

No fasting required

Starting dose. 500 mcg — Daily

SubQ injection, any time of day. 10-20 day courses, 2-3 cycles per year with 4-6 months between courses (Khavinson protocol). Pin alone or with other bioregulators only.

❋

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first

Conservative start

500 mcg daily · SubQ injection · 12 week course, monitor PSA

conservative starter

500 mcg daily

12 week course, monitor PSA

Standard

Prostate Tissue Repair (Oral capsule)

10-20 mg · Oral · Daily

anecdotal · community

Synthetic peptide for prostate health. This is the ORAL capsule dose and is not an injection dose. Oral peptide absorption is poor, so this figure is far higher than the injectable protocol on purpose. Do not inject this amount.

10-20 mg

Daily

Reconstitution CalculatorU-100

Vial strength

BAC water

Vials in this mix

Syringe size

Target dose

050100u

Draw to

— units

◆

I will split this dose across more than one syringe

◆

How it works

Prostamax modulates gene expression in prostatic epithelial cells, supporting balanced androgen receptor signaling, cellular proliferation control, and tissue maintenance pathways. May help normalize the gene expression changes associated with aging prostate tissue.

What to expect

Early

Days 1–7

Days 1-10: Gene changes initiated.

Mid

Weeks 2–4

Weeks 2-8: Prostate gene programs established.

Later

Weeks 4–12

Months: Sustained prostate tissue support.

Evidence

HumanPresent

AnimalPresent

In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

The synthetic peptides--cardiogen, bronchogen, prostamax and pancragen were used to investigate their effect on organotypic tissue culture of explants from heart, lungs, prostatic gland and pancreas of young (3-week old) and aged (18-month old) rats.

The synthetic peptides--cardiogen, bronchogen, prostamax and pancragen were used to investigate their effect on organotypic tissue culture of explants from heart, lungs, prostatic gland and pancreas of young (3-week old) and aged (18-month old) rats.

[The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]. Advances in gerontology = Uspekhi gerontologii · 2006 · PMID 17152728

Evidence scope. Organotypic tissue culture using rat prostate explants; not evidence for the displayed human subcutaneous course.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 500 mcg daily via SubQ injection, 12 week course, monitor PSA. No checked live PubMed abstract supported this complete molecule/formulation/route/dose/frequency combination.

Primary safety claim: Very well tolerated. No checked live abstract directly established this as the primary concern for the card's exact formulation and regimen.

The honest take

◆

BPH support

Bioregulatory mechanism targeting prostate-specific gene expression. Russian clinical data.

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

◆

Pin alone. Prostamax must not share a syringe with anything else, whatever the pharmacology says. PIN ALONE.

Documented together

TestagenProstamax prostate tissue + Testagen testicular tissue. Complementary male reproductive support. Run in sequence.

Keep separate

GHK-CuCopper degrades bioregulators.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

Side effects & safety

Commonly reported

Very well tolerated

Less common & notes

Monitor PSA.
Consult urologist if prostate concerns exist.

Pharmacokinetics

Illustrative plasma concentration · 2.0 h

Half-life

0.5h

Peak · Tmax

0.05h

Elimination

2.5h

Bioavailability

~100%

SubQ

Duration of action

Weeks to months (epigenetic gene expression changes persist beyond dosing course)

Clearance

Enzymatic degradation (aminopeptidases)

Storage. Standard BAC water 2-8C. 21-28 days.

Regulatory status

Not FDA-approved. Research peptide.

Put it to work

Calculate, log & track

Open Prostamax straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Prostamax in the app →

Go deeper

The guide & community

The complete Prostamax walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗

Open in app Community